Aralen

Aralen is a brand name of chloroquine, approved by the FDA in the following formulation(s):

ARALEN (chloroquine phosphate - tablet; oral)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): EQ 300MG BASE ^[RLD][AA]

Has a generic version of Aralen been approved?

Yes. The following products are equivalent to Aralen:

chloroquine phosphate tablet; oral

• 
  Manufacturer: IMPAX LABS
  
  Approval date: August 29, 2003
  
  Strength(s): EQ 300MG BASE ^[AA]


• 
  Manufacturer: IPCA LABS LTD
  
  Approval date: December 3, 2009
  
  Strength(s): EQ 300MG BASE ^[AA]


• 
  Manufacturer: NATCO PHARMA LTD
  
  Approval date: January 21, 2011
  
  Strength(s): EQ 300MG BASE ^[AA]


• 
  Manufacturer: WEST WARD
  
  Approval date: September 17, 1999
  
  Strength(s): EQ 300MG BASE ^[AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aralen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Aralen.

See also...

• Aralen Consumer Information (Wolters Kluwer)
• Aralen Tablets Consumer Information (Wolters Kluwer)
• Chloroquine Consumer Information (Wolters Kluwer)
• Chloroquine Tablets Consumer Information (Wolters Kluwer)
• Chloroquine Consumer Information (Cerner Multum)
• Chloroquine Oral, Intramuscular Advanced Consumer Information (Micromedex)
• Chloroquine Phosphate AHFS DI Monographs (ASHP)